3.250SEK-0.91%Mkt Cap: 12.07M $P/E: —Today
Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and …
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap12.07M $
Enterprise Value32.05M $
Revenue (TTM)44.12M $
Gross Profit20.45M $
Net Income (TTM)-358.98K $
Revenue/Share1.244 USD
Last Price3.250 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees200
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)2.90
PEG—
EV/EBITDA15.47
EV/Revenue0.73
P/S0.28
P/B0.73
EPS (TTM)-0.14
EPS (Forward)1.13
52W Range
2.75013% of range6.640
52W High6.640 SEK
52W Low2.750 SEK
Profitability
Gross Margin43.66%
Oper. Margin2.94%
EBITDA Margin4.69%
Profit Margin-0.77%
ROE-2.24%
ROA-0.80%
Growth
Revenue Growth-13.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF79.30K $
CapEx (TTM)474.72K $
FCF Margin0.21%
FCF Yield0.78%
Net Debt19.87M $
Net Debt/EBITDA9.59
Balance Sheet
Debt/Equity1.33
Current Ratio1.07
Quick Ratio0.68
Book Value/Sh4.504 SEK
Cash/Share0.5050 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield0.73%
Payout Ratio0.00%
Ex-Div DateMay 6, 2022
Pay Date—
Splits
Last Split4:1
Split DateJun 1, 2018
Analyst Consensus
Rating—
Target (Mean)3.800 SEK
Upside (mean)+16.9%
Target Range3.800 SEK – 3.800 SEK
# Analysts1
Ownership
Shares Out.38.83M
Float22.80M
Insiders35.31%
Institutions54.43%
Technical
SMA 503.583 (-9.3%)
SMA 2004.253 (-23.6%)
Beta0.18
S&P 52W Chg18.16%
Avg Vol (30d)35.11K
Avg Vol (10d)19.47K
Technical Indicators
RSI (14)39.0
MACD-0.0754
MACD Signal-0.0316
MACD Hist.-0.0438
BB Upper3.907 SEK
BB Middle3.554 SEK
BB Lower3.200 SEK
BB Width19.90%
ATR (14)0.2255 SEK
Vol Ratio (20d)0.10x